10.24
1.82%
-0.19
Iovance Biotherapeutics Inc (IOVA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
2.77%
0.482
|
0.469 | 0.238 | - | - |
Cost Of Revenue |
0.58%
4.365
|
4.34 | 2.05 | - | - |
Gross Profit |
0.31%
-3.883
|
-3.871 | -1.812 | - | - |
Operating Expenses
|
2.52%
117.37
|
114.49 | 108.27 | 110.86 | 107.04 |
Benefits Costs and Expenses |
2.73%
118.62
|
115.47 | 107.24 | 107.37 | - |
Costs And Expenses |
2.45%
121.74
|
118.83 | 110.32 | 110.86 | - |
Operating Income/Loss |
2.45%
-121.26
|
-118.36 | -110.09 | -110.86 | -107.04 |
Income/Loss From Continuing Operations Before Tax |
2.73%
-118.14
|
-115.00 | -107.00 | -107.37 | -105.32 |
Income Tax Expense/Benefit, Deferred |
41.51%
-1.759
|
-1.243 | - | - | - |
Income Tax Expense/Benefit |
41.51%
-1.759
|
-1.243 | -0.477 | - | - |
Income/Loss From Continuing Operations After Tax |
2.30%
-116.38
|
-113.76 | -106.53 | -107.37 | -105.32 |
Net Income/Loss
|
2.30%
-116.38
|
-113.76 | -106.53 | -107.37 | -105.32 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
192.70%
-227.88
|
245.82 | 224.48 | 213.69 | -157.24 |
Diluted Average Shares |
192.70%
-227.88
|
245.82 | 224.48 | 213.69 | -157.24 |
Basic Earnings Per Share |
2.17%
-0.45
|
-0.46 | -0.47 | -0.50 | -0.64 |
Diluted Earnings Per Share |
2.17%
-0.45
|
-0.46 | -0.47 | -0.50 | -0.64 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):